Anti-CD40-Antikörper

Patent europeic · EP2796467 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2796467
Numer da la dumonda
EP14168869
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-03-2011
Publitgà
29-10-2014
Concedì
28-03-2018
Stritgà
23-10-2026
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
C12N 15/13 (2006.01)
A61P 27/00 (2006.01)
A61P 37/00 (2006.01)
Prioritad
US 319574 P 31.03.2010
Derivà da
EP11712447
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-10-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2026

  2. 01-04-2025

    Next annual fee due on

    Next annual fee due on
    31.03.2025 → 31.03.2026

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 28-03-2018

    Concedì

    Published in Swissreg on 28.03.2018

Partidas

Possessur

Boehringer Ingelheim International GmbH

55216 Ingelheim am Rhein, DE

Inventur

Singh, Sanjaya

Ridgefield, CT 06877-0368, US

Litzenburger, Tobias

55216 Ingelheim am Rhein, DE

Brodeur, Scott

Ridgefield, CT 06877-0368, US

Canada, Keith A.

Ridgefield, CT 06877-0368, US

Barrett, Rachel

Ridgefield, CT 06877-0368, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.